Quantum Biopharma Class B Subordinate Voting Shares
QNTM
14 hedge funds and large institutions have $357K invested in Quantum Biopharma Class B Subordinate Voting Shares in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.
1,920% more call options, than puts
Call options by funds: $808K | Put options by funds: $40K
600% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 1
183% more capital invested
Capital invested by funds: $126K → $357K (+$231K)
75% more funds holding
Funds holding: 8 → 14 (+6)
0.01% more ownership
Funds ownership: 0.01% → 0.02% (+0.01%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Advisers
New York
|
+$138K |
| 2 |
WS
Wedbush Securities
Los Angeles,
California
|
+$126K |
| 3 |
VF
Virtu Financial
New York
|
+$33.6K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$32K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$5.81K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$3.74K |
| 2 |
SIM
Sonora Investment Management
Tucson,
Arizona
|
-$831 |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$208 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WS
1
Wedbush Securities
Los Angeles,
California
| $164K | +$126K | +607 | +159% |
|
|
2
Two Sigma Advisers
New York
| $110K | +$138K | +663 | New |
|
|
VF
3
Virtu Financial
New York
| $27K | +$33.6K | +162 | New |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $26K | +$32K | +154 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $12K | +$5.81K | +28 | +60% |
|
|
6
Bank of Montreal
Toronto,
Ontario, Canada
| $4K | -$208 | -1 | -4% |
|
7
Simplex Trading
Chicago,
Illinois
| $4K | +$5.61K | +27 | New |
|
|
8
Royal Bank of Canada
Toronto,
Ontario, Canada
| $3K | -$3.74K | -18 | -50% |
|
9
Morgan Stanley
New York
| $3K | +$3.12K | +15 | New |
|
|
FDCDDQ
10
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $2.03K | – | – | – |
|
11
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $1K | +$831 | +4 | +400% |
|
|
CG
12
Cutler Group
San Francisco,
California
| $1K | +$1.66K | +8 | New |
|
|
SIM
13
Sonora Investment Management
Tucson,
Arizona
| – | -$831 | -4 | -67% |
|
|
ASN
14
Advisory Services Network
Atlanta,
Georgia
| – | +$208 | +1 | New |
|
QNTM Hedge Fund Activity: Q3 2020 in Review
14 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Quantum Biopharma Class B Subordinate Voting Shares (QNTM) for Q3 2020, worth a combined $357K — up 183% from $126K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new QNTM positions and 1 closed out — a net gain of 6 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Two Sigma Advisers, opening a new position worth an estimated $138K. The largest seller was Royal Bank of Canada, cutting an estimated $3.74K.
- 14 institutional investors held Quantum Biopharma Class B Subordinate Voting Shares (QNTM) as of Q3 2020, up from 8 in Q2 2020.
- Funds reported $357K of Quantum Biopharma Class B Subordinate Voting Shares stock for Q3 2020, up 183% quarter-over-quarter.
- 7 funds opened new Quantum Biopharma Class B Subordinate Voting Shares positions in Q3 2020 and 1 closed out, a net change of +6 holders.
- The largest Quantum Biopharma Class B Subordinate Voting Shares buyer in Q3 2020 was Two Sigma Advisers, an estimated $138K added.
- The largest Quantum Biopharma Class B Subordinate Voting Shares seller in Q3 2020 was Royal Bank of Canada, an estimated $3.74K sold.
Based on aggregated 13F filings for Q3 2020.